"Supreme Court's Review of Mifepristone Suit: The Far Right's Influence on Abortion Access"

A pharmacy professor's email complaint led to the retraction of three anti-abortion research papers, highlighting the use of poor-quality evidence by right-wing groups to influence abortion litigation and legislation. The upcoming US Supreme Court case, FDA v AHM, could reshape abortion access and the FDA's authority, with potential implications for other controversial drugs. The anti-abortion movement invests in research to produce evidence for litigation and legislation, often using fringe publications and academic journals. Despite efforts to challenge poor-quality evidence, the battle remains difficult, as journals can be reluctant to correct the scientific record.